Ciprofloxacin Pharmacokinetics in Clinical Canine Patients.

about

Population Pharmacokinetic Study of Cefazolin Used Prophylactically in Canine Surgery for Susceptibility Testing Breakpoint Determination

P2860

Q57816952-80F8B074-C230-4B3F-B4B3-8FFEA72A42D8

P2860

Ciprofloxacin Pharmacokinetics in Clinical Canine Patients.

Item

http://www.wikidata.org/entity/Q38644145

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Ciprofloxacin Pharmacokinetics in Clinical Canine Patients.

@en

type

Item

label

Ciprofloxacin Pharmacokinetics in Clinical Canine Patients.

@en

prefLabel

Ciprofloxacin Pharmacokinetics in Clinical Canine Patients.

@en

P1476

Ciprofloxacin Pharmacokinetics in Clinical Canine Patients

@en

P2093

M G Papich

http://www.w3.org/2001/XMLSchema#string

P2860

Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.

Setting and revising antibacterial susceptibility breakpoints.

Pharmacokinetics of a novel quinolone, AT-4140, in animals.

Effect of Sucralfate on the Relative Bioavailability of Enrofloxacin and Ciprofloxacin in Healthy Fed Dogs.

Ciprofloxacin pharmacokinetics in dogs following oral administration.

Effect of generics on price and consumption of ciprofloxacin in primary healthcare: the relationship to increasing resistance.

Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs.

Ciprofloxacin pharmacokinetics and oral absorption of generic ciprofloxacin tablets in dogs.

Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia.

Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

P304

1508-1513

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JVIM.14788

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mark Papich

P577

2017-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28771831

http://www.w3.org/2001/XMLSchema#string

P932

5598882

http://www.w3.org/2001/XMLSchema#string

Ciprofloxacin Pharmacokinetics in Clinical Canine Patients.

about

P2860

P2860

Ciprofloxacin Pharmacokinetics in Clinical Canine Patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932